Advertisement
Advertisement

MOLN

MOLN logo

Molecular Partners AG - ADR

3.80
USD
Sponsored
-0.01
-0.26%
Jun 24, 15:48 UTC -4
Closed
exchange

Pre-Market

3.91

+0.11
+2.89%

Molecular Partners AG - ADR Profile

About

Molecular Partners AG is a clinical-stage biotech company. It involved in developing a new class of custom-built protein drugs known as DARPin(R) therapeutics. Molecular Partners AG is based in SWITZERLAND.

Info & Links

CEO

Patrick Amstutz

Headquarters

WAGISTRASSE 14,SCHLIEREN
ZURICH, V8 8952, SWITZERLAND

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.molecularpartners.com

Auditor

KPMG AG

Share holders

5

Employees

134

Molecular Partners AG - ADR Statistics

Valuation Measures

Market Capitalization2

146.67M

Enterprise Value

66.22M

Enterprise Value/EBITDA(ttm)

-0.99

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.80

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-60.62%

Return on Invested Capital(ttm)

-61.35%

Return on Assets(ttm)

-51.84%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

-47.31M

EBITDA(ttm)3

-66.74M

Net Income Available to Common(ttm)

-72.53M

Diluted EPS(ttm)

-1.99

Share Statistics

Beta (5Y Monthly)

1.11

52-Week Change

6.15%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

37.98M

% Held by Insiders

5.93%

% Held by Institutions

26.55%

Balance Sheet

Total Cash(mrq)

100.52M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

1.54M

Total Debt/Equity(mrq)

1.50%

Current Ratio(mrq)

8.79%

Quick Ratio(mrq)

8.79%

Book Value Per Share(mrq)

2.40

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.66

Free Cash Flow(ytd)

-62.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement